Lv5
1306 积分 2025-02-28 加入
Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
5天前
已完结
Preparation and in vitro/in vivo evaluation of uniform-sized Goserelin-loaded sustained release microspheres
13天前
已完结
Goserelin/PLGA solid dispersion used to prepare long-acting microspheres with reduced initial release and reduced fluctuation of drug serum concentration in vivo
13天前
已完结
Clinical Pharmacokinetics of Depot Leuprorelin
14天前
已完结
Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use
14天前
已完结
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
15天前
已完结
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
20天前
已完结
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
22天前
已完结
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
22天前
已完结
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph Nodes
28天前
已完结
皖公网安备34019202002308
